missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human BPHL (aa 188-270) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (84%), Rat (84%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-57799 (PA5-57799. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Serine hydrolase that catalyzes the hydrolytic activation of amino acid ester prodrugs of nucleoside analogs such as valacyclovir and valganciclovir. Activates valacyclovir to acyclovir. May play a role in detoxification processes. It is a specific alpha-amino acid ester hydrolase that prefers small, hydrophobic, and aromatic side chains and does not have a stringent requirement for the leaving group other than preferring a primary alcohol.
Specifications
Specifications
| Accession Number | Q86WA6 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 670 |
| Name | Human BPHL (aa 188-270) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2010012D11Rik; 5730533B08Rik; AI115341; biphenyl hydrolase-like (serine hydrolase); biphenyl hydrolase-like (serine hydrolase, breast epithelial mucin-associated antigen); biphenyl hydrolase-like protein; Biphenyl hydrolase-related protein; BPHL; BPH-RP; Breast epithelial mucin-associated antigen; MCNAA; PARG; Poly(ADP-ribose) glycohydrolase; VACVASE; valacyclovir hydrolase; valacyclovirase |
| Common Name | BPHL |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction